MyMD Pharmaceuticals (NASDAQ:MYMD) Stock Price Up 8.6% – Here’s What Happened

MyMD Pharmaceuticals, Inc. (NASDAQ:MYMDGet Free Report)’s share price traded up 8.6% during trading on Friday . The stock traded as high as $1.72 and last traded at $1.65. 12,081 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 134,123 shares. The stock had previously closed at $1.52.

MyMD Pharmaceuticals Stock Up 8.6 %

The company has a 50-day moving average price of $1.64 and a 200 day moving average price of $2.00.

MyMD Pharmaceuticals Company Profile

(Get Free Report)

MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.

Read More

Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.